Kala Pharmaceuticals stock rockets nearly 300% after FDA OKs IND application for PCED treatment

Shares of Kala Pharmaceuticals Inc. KALA, +219.90% quadrupled in very volatile trading Wednesday, after the biopharmaceutical company said the Food and Drug Administration accepted its investigational...